Covid-19 roundup: Pfiz­er, BioN­Tech set new pro­duc­tion quo­ta for vac­cine at 2B dos­es in 2021; New da­ta show IL-6 in­hibitor could be ef­fec­tive treat­ment af­ter all

Pfiz­er and BioN­Tech are well on their way to a glob­al roll­out of their mR­NA-based Covid-19 vac­cine, BTN162b2. Even with lo­gis­ti­cal chal­lenges ham­per­ing that plan …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER